First-time generic drug approvals, January 2009

Generic drugs approved by FDA (through January 2009) including rocuronium injection and budesonide inhalation suspension

Rocuronium injection, 50 mg/5 mL (equiv to Zemuron injection)
GENERAMEDIX, HOSPIRA, TEVA

Budesonide inhalation suspension, 0.25 mg/2 mL and 0.5 mg/2 mL (equiv to Pulmicort Respules)
TEVA